Efficacy of Favipiravir in treatment of mild &amp; moderate COVID-19 infection in Nepal: a multi-center, randomized, open-labelled, phase III clinical trial

International Journal of Infectious Diseases (2022) - Comments
doi: 10.1016/j.ijid.2021.12.109 issn: 1201-9712

P. Adhikari, J. Koirala, A. Shrestha, N. Bista, K. Maleku, J. Das, K. Bhandari, N. Adhikari, A. Rawal, K. Pandit, P. Gyawali, S. Pant